메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Byung Chul Jung (University of California) Sung-Hun Woo (Yonsei University) Sung Hoon Kim (Yonsei University) Yoon Suk Kim (Yonsei University)
저널정보
대한생화학·분자생물학회 BMB Reports BMB Reports Vol.57 No.2
발행연도
2024.2
수록면
104 - 109 (6page)
DOI
https://doi.org/10.5483/BMBRep.2023-0225

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Gefitinib exerts anticancer effects on various types of cancer,such as lung, ovarian, breast, and colon cancers. However, thetherapeutic effects of gefitinib on cervical cancer and the un derlying mechanisms remain unclear. Thus, this study aimedto explore whether gefitinib can be used to treat cervical cancerand elucidate the underlying mechanisms. Results showed thatgefitinib induced a caspase-dependent apoptosis of HeLa cells,which consequently became round and detached from thesurface of the culture plate. Gefitinib induced the reorganiza tion of actin cytoskeleton and downregulated the expression ofp-FAK, integrin β1 and E-cadherin, which are important in cell extracellular matrix adhesion and cell-cell interaction, respecti vely. Moreover, gefitinib hindered cell reattachment and spread ing and suppressed interactions between detached cells insuspension, leading to poly (ADP-ribose) polymerase cleavage,a hallmark of apoptosis. It also induced detachment-inducedapoptosis (anoikis) in C33A cells, another cervical cancer cellline. Taken together, these results suggest that gefitinib triggersanoikis in cervical cancer cells. Our findings may serve as abasis for broadening the range of anticancer drugs used to treatcervical cancer.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

최근 본 자료

전체보기

댓글(0)

0